Gut Healing — Benefits Deep Dive
Gut healing is the practical project of restoring an intestinal epithelium that has lost its barrier integrity — the condition popularized as "leaky gut" and formalized in the medical literature as increased intestinal permeability. The single-cell-thick epithelial monolayer separating the gut lumen from systemic circulation is the largest mucosal surface in the body (approximately 32 square meters in adults) and the site where dietary, microbial, and immunological inputs are continuously negotiated. When tight junctions fail, undigested food peptides and microbial antigens translocate into the lamina propria and drive chronic low-grade systemic inflammation. The four deep-dive pages below cover four widely used approaches to restoring barrier function: a structured elimination-and-reintroduction diet (GAPS, a practitioner protocol with no published trials), the amino acid that is the primary fuel of enterocytes (glutamine, delivered via bone broth and isolated supplementation), the bacterial strains with the strongest barrier-repair evidence (Lactobacillus rhamnosus GG, Saccharomyces boulardii, multi-strain high-concentration probiotic mixtures), and the practical work of identifying and removing the specific triggers (nonsteroidal anti-inflammatory drugs (NSAIDs), alcohol, gluten, glyphosate, chronic stress) that perpetuate epithelial damage.
Deep-Dive Articles
GAPS Diet
Dr. Natasha Campbell-McBride's Gut and Psychology Syndrome protocol — a phased introduction diet that begins with homemade meat-stock and well-cooked non-fibrous vegetables, then progresses through six stages over weeks to months. The mechanism is two-fold: removal of fermentable carbohydrates that feed dysbiotic flora, and aggressive provision of the collagen, glycine, and free amino acids that epithelial repair requires. Includes practical staging, common pitfalls, the related Specific Carbohydrate Diet (SCD), and what is and is not known (no GAPS trial has been published).
Read the deep dive →Bone Broth and Glutamine
Glutamine is the primary metabolic fuel of enterocytes — small-intestinal cells preferentially oxidize glutamine over glucose for adenosine triphosphate (ATP). Bone broth supplies glycine, proline, hydroxyproline, and collagen peptides, the building blocks practitioners link to tight junction protein synthesis; the one measured analysis found these amino acids highly variable between recipes and lower in standard-recipe broth than in a 20 g collagen supplement dose (glutamine was not among the amino acids it measured). Covers traditional 24-72 hour simmer preparation, isolated L-glutamine supplementation (5-15 g/day clinical dosing), the bovine and marine collagen alternatives, and the mechanism behind glutamine's claudin-1 and ZO-1 tight junction upregulation.
Read the deep dive →Probiotic Strains for Repair
Not all probiotics heal the gut equally — the strain-specific evidence is what matters. Lactobacillus rhamnosus GG has the strongest barrier-repair evidence in pediatric and adult trials. Saccharomyces boulardii is the only yeast probiotic with rigorous antibiotic-associated diarrhea evidence. The original eight-strain high-dose probiotic mixture studied in the pouchitis and ulcerative colitis trials is the high-concentration multi-strain formulation with the strongest ulcerative colitis evidence. Bifidobacterium infantis 35624 was tested in a 362-woman trial covering all IBS bowel-habit types, where only the middle dose (100 million colony-forming units) beat placebo for abdominal pain. Includes colony-forming unit (CFU) dosing, refrigeration requirements, the post-antibiotic recolonization window, and contraindications in immunocompromise.
Read the deep dive →Avoiding Triggers
The single most-overlooked aspect of gut healing — a tissue that is continuously re-injured does not get the chance to heal. The major modifiable epithelial-damage drivers are nonsteroidal anti-inflammatory drugs (ibuprofen, naproxen, aspirin), alcohol, gluten (in celiac and non-celiac wheat-sensitive patients), glyphosate residue, chronic psychological stress (via corticotropin-releasing factor (CRF)-mediated mast-cell activation and gut barrier disruption), and chronic infection (Helicobacter pylori, small intestinal bacterial overgrowth (SIBO)). This page covers practical identification protocols (food and symptom diaries, lactulose-mannitol gut permeability testing), and a structured elimination-and-reintroduction approach.
Read the deep dive →Table of Contents
- Deep-Dive Articles
- Why Gut Healing Requires a Multi-Pronged Approach
- Research Papers: Dietary Interventions (GAPS, SCD, Low-FODMAP)
- Research Papers: Glutamine and Bone Broth
- Research Papers: Probiotic Strain-Specific Evidence
- Research Papers: Triggers and Permeability
- Research Papers: Cross-Cutting (Barrier Biology, Microbiome)
- External Authoritative Resources
- Connections
- Featured Videos
Why Gut Healing Requires a Multi-Pronged Approach
The gut lining is large, though smaller than the “tennis court” of older textbooks: careful measurement puts the inner surface of the whole adult digestive tract at about 32 square meters — about half a badminton court — of which about 2 square meters is the large intestine (Helander and Fändriks, 2014).
Increased intestinal permeability does not arise from a single cause and rarely resolves through a single intervention. The intestinal epithelium is a dynamic tissue with a turnover cycle of three to five days — the entire surface is replaced approximately every week through proliferation in crypt stem cell niches and migration up the villus axis. This high turnover means the barrier can be either rapidly damaged or rapidly restored, depending on the balance of inputs. Three input categories interact:
- Substrate provision — enterocytes preferentially burn glutamine for adenosine triphosphate, and the tight junction proteins (claudins, occludin, zonula occludens-1) require continuous synthesis from dietary amino acids. Inadequate protein intake, chronic catabolic illness, or restricted-amino-acid diets impair repair regardless of other interventions. This is the mechanistic case for bone broth and free L-glutamine supplementation.
- Microbial signaling — commensal bacteria signal continuously to the epithelium via short-chain fatty acid metabolites (butyrate is the primary fuel of colonocytes), pattern-recognition receptor ligands, and direct cell-cell contact. Dysbiosis (loss of butyrate producers, overgrowth of pathobionts) disrupts these signals and degrades the barrier. This is the case for targeted probiotic strains with documented barrier-restoration evidence.
- Trigger removal — ongoing chemical, mechanical, or immunological injury (nonsteroidal anti-inflammatory drugs, alcohol, gluten in sensitive individuals, chronic stress) prevents repair regardless of nutritional and microbial support. Identifying and removing the active drivers is necessary but rarely sufficient on its own.
The fourth element — structured dietary reintroduction protocols like GAPS and the Specific Carbohydrate Diet — sits at the intersection of all three. By simultaneously providing dense amino-acid and gelatin substrate, removing fermentable substrate that feeds dysbiotic flora, and acting as a long elimination-and-reintroduction trigger-identification protocol, these structured diets, in their practitioners' account, address all three input categories in parallel. The trade-off is high adherence demand and the risk of nutritional inadequacy if the diet is not properly executed.
What is not known. The evidence behind these approaches is uneven. For glutamine, a 2019 randomized placebo-controlled trial in Gut gave 5 g three times a day for 8 weeks to adults who developed diarrhoea-type irritable bowel syndrome with a leaky gut after a gut infection: 43 of 54 people on glutamine (79.6%) reached the main improvement target, against 3 of 52 on placebo (5.8%), and the raised leaky-gut test (urinary lactulose/mannitol ratio) returned to normal on glutamine but not on placebo. A 2024 meta-analysis that pooled 10 placebo-controlled trials of glutamine by mouth (352 adults, published 1998–2014), however, found that overall glutamine “did not significantly affect intestinal permeability”; a reduction appeared only in a subgroup given high doses (reported as over 30 g a day) for less than two weeks. For bone broth, a 2019 laboratory analysis found the amino-acid content varied widely between recipes, and that standard-recipe broths were significantly lower in glycine, proline and hydroxyproline than a 20 g collagen supplement dose; its authors concluded “it is unlikely that BB [bone broth] can provide a consistently reliable source of key amino acids.” For GAPS, no trial has been published; the protocol rests on Dr. Natasha Campbell-McBride's practitioner experience and the reports of people who follow it.
For a comprehensive overview of the conditions associated with leaky gut and the broader case for barrier restoration, see the main Gut Healing page.
Research Papers: Dietary Interventions (GAPS, SCD, Low-FODMAP)
- Suskind DL et al., Specific Carbohydrate Diet for inflammatory bowel disease (J Pediatr Gastroenterol Nutr) — PubMed: SCD for IBD
- Cohen SA et al., Clinical and mucosal improvement with SCD in pediatric Crohn's disease — PubMed: SCD mucosal healing
- Halmos EP et al., Low-FODMAP diet RCT for IBS (Gastroenterology) — PubMed: Low-FODMAP RCT
- Campbell-McBride N, Gut and Psychology Syndrome (book) — the author's own protocol, a practitioner source rather than a research paper; no GAPS trial or clinical series is indexed in PubMed.
- Konijeti GG et al., Autoimmune Protocol Diet (AIP) for inflammatory bowel disease — PubMed: AIP for IBD
- Suskind DL et al., Maintenance of remission with SCD in Crohn's disease — PubMed: SCD maintenance
- Olendzki BC et al., Anti-inflammatory diet for ulcerative colitis case series — PubMed: Anti-inflammatory diet
- Levine A et al., Crohn's Disease Exclusion Diet (CDED) RCT — PubMed: CDED RCT
- Reddel S et al., Impact of Low-FODMAP diet on gut microbiota composition — PubMed: FODMAP microbiota
Research Papers: Glutamine and Bone Broth
- Wischmeyer PE, Glutamine and gut barrier function in critical illness — PubMed: Glutamine in critical care
- van der Hulst RR et al., Glutamine and the preservation of gut integrity (Lancet) — PubMed: van der Hulst Lancet
- Rao R, Samak G, Role of glutamine in protection of intestinal epithelial tight junctions — PubMed: Glutamine tight junctions
- Zhou Q, Verne ML, Fields JZ, Lefante JJ, Basra S, Salameh H, Verne GN. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut 2019;68(6):996–1002. 5 g three times a day for 8 weeks; 79.6% vs 5.8% reached the main target, and the leaky-gut test normalised on glutamine — PubMed PMID: 30108163
- Benjamin J et al., Glutamine in Crohn's disease (intestinal permeability) — PubMed: Glutamine in Crohn's
- Newsholme P, Why is L-glutamine metabolism important to cells of the immune system — PubMed: Newsholme glutamine immunology
- Abbasi F, Haghighat Lari MM, Khosravi GR, Mansouri E, Payandeh N, Milajerdi A. A systematic review and meta-analysis of clinical trials on the effects of glutamine supplementation on gut permeability in adults. Amino Acids 2024;56(1):60. 10 trials, 352 adults: no significant overall effect on permeability — PubMed PMID: 39397201
- Alcock RD, Shaw GC, Burke LM. Bone Broth Unlikely to Provide Reliable Concentrations of Collagen Precursors Compared With Supplemental Sources of Collagen Used in Collagen Research. International Journal of Sport Nutrition and Exercise Metabolism 2019;29(3):265–272 — PubMed PMID: 29893587
Research Papers: Probiotic Strain-Specific Evidence
- Szajewska H et al., Lactobacillus rhamnosus GG meta-analyses (acute diarrhea, antibiotic-associated diarrhea) — PubMed: LGG meta-analysis
- McFarland LV, Saccharomyces boulardii meta-analysis (CDI, AAD) — PubMed: S. boulardii meta-analysis
- Gionchetti P et al., VSL#3 for pouchitis (Gastroenterology) — PubMed: VSL#3 pouchitis
- Tursi A et al., VSL#3 for active ulcerative colitis — PubMed: VSL#3 ulcerative colitis
- Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. American Journal of Gastroenterology 2006;101(7):1581–1590. 362 women, any bowel-habit type; only the 1 × 108 CFU dose beat placebo — PubMed PMID: 16863564
- Sanders ME et al., Probiotics and prebiotics in intestinal health and disease (Nat Rev Gastro) — PubMed: Sanders Nat Rev
- Hill C et al., Expert consensus statement on the scope of probiotics (ISAPP) — PubMed: ISAPP consensus
- Bron PA et al., Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa — PubMed: Probiotic-host interaction
- Goldenberg JZ et al., Probiotics for the prevention of Clostridium difficile-associated diarrhea (Cochrane) — PubMed: Probiotics for CDI Cochrane
- Doron S, Snydman DR, Risk and safety of probiotics — PubMed: Probiotic safety
Research Papers: Triggers and Permeability
- Bjarnason I et al., NSAIDs and the small intestine: enteropathy mechanism — PubMed: NSAID enteropathy
- Bode JC, Bode C, Effect of alcohol consumption on the gut — PubMed: Alcohol and gut permeability
- Hollon J et al., Effect of gliadin on permeability in celiac and non-celiac patients (Nutrients) — PubMed: Gliadin permeability
- Drago S et al., Gliadin, zonulin, and gut permeability — PubMed: Gliadin and zonulin
- Samsel A, Seneff S, Glyphosate, pathways to modern diseases (review of toxicity hypotheses) — PubMed: Glyphosate hypothesis
- Vanuytsel T et al., Psychological stress and corticotropin-releasing hormone increase intestinal permeability (Gut) — PubMed: Stress and CRH permeability
- Wallon C et al., Mast cells, CRH and gut barrier function — PubMed: Mast cells and gut barrier
- Camilleri M, Leaky gut: mechanisms, measurement, and clinical implications in humans — PubMed: Camilleri leaky gut review
- Fasano A, Zonulin and its regulation of intestinal barrier function — PubMed: Fasano zonulin
- Bischoff SC et al., Intestinal permeability — a new target for disease prevention and therapy (BMC Gastro) — PubMed: Bischoff permeability review
Research Papers: Cross-Cutting (Barrier Biology, Microbiome)
- Turner JR, Intestinal mucosal barrier function in health and disease (Nat Rev Immunol) — PubMed: Turner barrier review
- Suzuki T, Regulation of intestinal epithelial permeability by tight junctions — PubMed: Suzuki tight junctions
- Furusawa Y et al., Commensal microbe-derived butyrate induces colonic Tregs (Nature) — PubMed: Butyrate Tregs
- Atarashi K et al., Treg induction by a rationally selected mixture of Clostridia strains — PubMed: Clostridia and Tregs
- Sender R et al., Revised estimates for the number of human and bacteria cells in the body — PubMed: Sender microbiome census
- Sonnenburg JL, Backhed F, Diet-microbiota interactions as moderators of human metabolism — PubMed: Diet-microbiota
- Vetrano S et al., Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis — PubMed: JAM-A and mucosa
- Round JL, Mazmanian SK, The gut microbiota shapes intestinal immune responses (Nat Rev Immunol) — PubMed: Round/Mazmanian microbiota immunity
- Maslowski KM et al., Regulation of inflammatory responses by gut microbiota and short-chain fatty acids — PubMed: Maslowski SCFA
- Mu Q et al., Leaky gut as a danger signal for autoimmune diseases (Frontiers in Immunology) — PubMed: Mu leaky gut autoimmunity
- Helander HF, Fändriks L. Surface area of the digestive tract — revisited. Scandinavian Journal of Gastroenterology 2014;49(6):681–689. About 32 m² in total, about 2 m² of it the large intestine — PubMed PMID: 24694282
External Authoritative Resources
- NIDDK — Digestive Diseases Information (U.S. National Institutes of Health (NIH) authoritative resource on inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac)
- American Gastroenterological Association (AGA guidelines, clinical practice updates)
- Crohn's & Colitis Foundation (patient resources, diet research updates)
- International Scientific Association for Probiotics and Prebiotics (ISAPP)
- PubMed — All research on intestinal permeability / leaky gut